Article

Haag-Streit Surgical will market microscopes in the U.S.

Haag-Streit USA announces the launch of Haag-Streit Surgical, a new division that will market a line of surgical microscopes.

 

Mason, OH-Haag-Streit USA announces the launch of Haag-Streit Surgical, a new division that will market a line of surgical microscopes that already enjoy significant market share throughout Europe. The devices, formerly known as Möller-Wedel, are now being offered in the United States under the new Haag-Streit Surgical brand. 

“This line of surgical microscopes is well established in Europe,” said Ernest Cavin, Haag-Streit USA chief executive officer. “Now American ophthalmologists, neurosurgeons, and otolaryngologists will have better access to devices with a proven record of superior optics. This launch offers a new choice for the marketplace-one that will benefit doctors and their patients.”

The Hi-R NEO 900 is a universal microscope for surgical procedures, such as ophthalmology, that require vertical observation. The surgical microscope line, including the Hi-R NEO 900, will be on display at the Haag-Streit booth at ophthalmology conferences throughout 2013.

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.